TrialDiabetes & metabolism journal2024

Comparative Efficacy of Rosuvastatin Monotherapy and Rosuvastatin/Ezetimibe Combination Therapy on Insulin Sensitivity and Vascular Inflammatory Response in Patients with Type 2 Diabetes Mellitus.

Ji Hye Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.